VCID: 14396353
Profile

Corporate information

Investment activity status
Active investor

Selected investments

Country Date Notes
Avanir Pharmaceuticals Inc
A biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. 		United States 1 Dec 2014 Acquisition
USD 3,500,000,000 (USD 3,500,000,000) deal size. Initial investment. Led the investment round. Active

DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.